Navigation Links
Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets
Date:3/5/2009

PRINCETON, N.J., March 5 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Quinapril Hydrochloride & Hydrochlorothiazide (Quinapril + HCTZ) Tablets, 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg. The Application for the drug was submitted by Ranbaxy, from its Ohm Laboratories manufacturing facility located in North Brunswick, New Jersey. The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Accuretic(R) Tablets of Pfizer Pharmaceuticals Ltd. Total annual market sales for Quinapril + HCTZ Tablets were $29 million (IMS - MAT: December 2008).

According to Jim Meehan, Vice President of Sales and Distribution for RPI, "We are pleased to receive this final approval for Quinapril + HCTZ, an ACE inhibitor that is used to treat high blood pressure. This is the second ANDA approval granted by the FDA, to Ranbaxy, in the last two months. Product will be made available to all classes of trade in the near term."

Ohm, based in North Brunswick, New Jersey, is a wholly owned subsidiary of Ranbaxy Laboratories Limited. Ohm is engaged in the sale and distribution of generic and branded private label, OTC products in the U.S. healthcare system.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India's largest pharmaceutical company. RPI is engaged in the sale and distribution of generic and branded prescription products in the U.S. healthcare system.

Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research based, international pharmaceutical company producing a wide range of quali
'/>"/>

SOURCE Ranbaxy Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Press Statement Issued by Ranbaxy Laboratories Limited
2. Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
3. Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide
4. Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
5. Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Oral Solution
6. Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
7. Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg
8. Ranbaxy Receives Tentative Approval For Valsartan Tablets
9. Ranbaxy First to Gain Approval to Manufacture and Market Clarithromycin for Oral Suspension, USP
10. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
11. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... 2015 , ... Renowned review site BestMillionaireDatingSites.com recently refreshed its list of the ... ranked as the best dating service in the segment. , A representative from the ... essential that people find the right dating platform so that they can make the ...
(Date:8/4/2015)... ... August 05, 2015 , ... The National Association ... inductee into its VIP Woman of the Year Circle. She is recognized with ... organization exclusively for professional women, boasting more than 700,000 members and over 200 ...
(Date:8/4/2015)... ... ... NOVA Pride , Northern Virginia’s largest and newest LGBTQ nonprofit organization, invites ... them in paving “The Road Ahead” at the second annual Northern Virginia Pride Festival, ... from 12-9pm. In order to ensure the success of this important event, NOVA Pride ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... How cool ... share what inspires you via geolocation? The new "Now" feature will soon allow you ... will be able to inspire each other using the now feature. , Users will ...
(Date:8/4/2015)... ... August 04, 2015 , ... Statement by Paul Gionfriddo, ... introduction of the Mental Health Reform Act of 2015 by Senators Bill ... health reform a reality in America. , “This legislation and H.R. 2646 ...
Breaking Medicine News(10 mins):Health News:BestMillionaireDatingSites.com Publishes Reviews of the Best Dating Sites for Wealthy Singles 2Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 3Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 4Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3
... say , WEDNESDAY, Nov. 21 (HealthDay News) -- ... certain sounds, such as the sound of a familiar voice ... Washington, Seattle, and the University of California, Los Angeles, ... activity associated with a given sound task can also identify ...
... vascular disease is widespread and often deadly among older ... treat it, according to a new report by a ... Center and Weill Cornell Medical College campuses of NewYork-Presbyterian ... fact that for years, cardiovascular research has focused almost ...
... Revenues Increase 89% to $3.51 Million versus $1.85 ... Million for Q3 of 2006, -- Third ... ... /Xinhua-PRNewswire-FirstCall/ -- China Yingxia,International, Inc. (OTC Bulletin Board: CYXI), a leading provider in ...
... Eclipsys Corporation(R),(Nasdaq: ECLP ), The Outcomes ... Merrill Lynch Health Services Investor Conference,taking place next ... http://www.newscom.com/cgi-bin/prnh/20050209/FLW006LOGO ), Eclipsys executives will present ... a.m. Eastern time. Interested parties are invited to,listen ...
... 21 Shamir,Optical Industry Ltd. (Nasdaq: SHMR ) ... on Tuesday, November 27, 2007, and has,scheduled a conference ... that,morning., The conference call will be broadcast live ... http://www.kcsa.com approximately five minutes before,the conference call ...
... best value for money, study finds , WEDNESDAY, Nov. 21 ... and programs to improve the quality and value of their ... 21 issue of the Journal of the American Medical ... 609 executives of the largest employers in 41 U.S. ...
Cached Medicine News:Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 3Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 4Health News:China Yingxia International Announces 2007 Third Quarter Financial Results Conference Call 2Health News:China Yingxia International Announces 2007 Third Quarter Financial Results Conference Call 3Health News:China Yingxia International Announces 2007 Third Quarter Financial Results Conference Call 4Health News:China Yingxia International Announces 2007 Third Quarter Financial Results Conference Call 5Health News:Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 2Health News:Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 3Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing Third Quarter 2007 Earnings Results 2Health News:Most U.S. Companies Do Little to Boost Worker Health Benefits 2
(Date:8/4/2015)... , England , Aug. ... and UK biotechnology company Synairgen plc (LSE: SNG) today announced ... selective inhibitor to the lysyl oxidase type 2 enzyme (LOXL2) ... IPF affects in the region of 100,000 ... global revenues in excess of $1.1 billion by 2017. The LOXL2 ...
(Date:8/4/2015)... On August 3, 2015, a press conference on ... a donation ceremony of a million masks by Wuhan Longfeixiang ... Beijing . Wuhan Longfeixiang ... of Hubei Longfeixiang Industrial Group, which has successfully developed ... Baihe anti-pollution mask, filling the global gap for masks ...
(Date:8/4/2015)... Ill. , Aug. 4, 2015 ... dental supplies and equipment, today announced the acquisition ... Medical Products Laboratories, Inc. ("MPL PDCMD"). MPL PDCMD ... used in preventive and restorative dental procedures. ... expansion of our business in attractive, high-growth segments," ...
Breaking Medicine Technology:Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 2Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 3Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2
... STOCKHOLM, May 15, 2012 Medivir AB ... infectious diseases, announced today that it has appointed Henric ... commercial activities. Henric, who will have overall responsibility for ... in August 2012 and will be part of the ...
... May 14, 2012 Top leaders representing America,s ... discuss pressing public policy issues affecting job creation and medical ... than $20 billion medical device tax set to begin in ... and Jim Renacci (R-Ohio) joined Walter M Rosebrough, president and ...
Cached Medicine Technology:New Executive Vice President Commercial Appointed 2AdvaMed & BioOhio Discuss MedTech Impact on Ohio's Economy, Job Creation 2AdvaMed & BioOhio Discuss MedTech Impact on Ohio's Economy, Job Creation 3
... specialty Eraser instruments have been designed ... the right tool for situations requiring ... series of 25 gauge intraocular, bipolar, ... treatment of target tissues for fine-tip ...
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
... explanation of foldable intraocular lenses. The instrument ... placed under the implant and divides the ... helps support both halves of the lens ... in the anterior chamber is avoided. The ...
Medicine Products: